Clinical Trial Update: Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing

View source ↗

Summary

A completed pharmacosurveillance trial evaluating Xolair (omalizumab) dosing in patients with and without a history of anaphylactic reactions, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Allergic Asthma | Status: COMPLETED | Results posted: 2015-09-15